In all of the excitement about Covid-19 Personal protective equipment (such as face masks, etc.) testing strategies, such as our CLINITEST COVID-19 rapid tests and Vaccines, little focus has been paid to Covid-19 treatments, which is astonishing, considering the fact that the first effective, registered drug for COVID-19 treatment, AVIFAVIR®, is ready to be delivered.
AVIFAVIR® is an antiviral medication / drug, used to treat influenza, clinical studies have shown that AVIFAVIR enabled SARS-CoV-2 viral clearance and was safe and well-tolerated. When using AVIFAVIR®, patients:
Report on summary of efficacy and safety post-marketing study of AVIFAVIR® in 940 patients with COVID-19 showed that the drug is efficient and save and has a number of positive impacts: